Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.
-
Upload
meghan-barker -
Category
Documents
-
view
214 -
download
0
Transcript of Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.
![Page 1: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/1.jpg)
Applications of Lead aVR
ECG RoundsFebruary 15, 2007James Huffman, PGY-1
![Page 2: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/2.jpg)
Outline
1. Background2. Discussion and Practice
a) LMCA occlusionb) Acute Pericarditisc) TCA Cardiotoxicityd) Preexcitation syndrome
tachycardia
3. Review
![Page 3: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/3.jpg)
Background on lead aVR
Augmented unipolar limb lead
Placed on the lateral aspect of the R arm
Examines R upper portion of the heart (includes RV outflow tract and basal septum)
Largely ignored or used to confirm correct placement of other leads (Gorgels, 2001)
![Page 4: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/4.jpg)
Case 1
58M with RSCP.Onset while walking into work from carPressureRadiates to jaw and L arm
PMHx:MI (2001), DM-2, HTN, High
Cholesterol
![Page 5: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/5.jpg)
Case 1
![Page 6: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/6.jpg)
Case 1
Diagnosis?ST Elevation ACS
Territory?Anterior wall
Vessel(s)?Left main coronary artery (wait and
see)
![Page 7: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/7.jpg)
Application 1ACS from left main coronary artery obstruction
Certain obstruction patterns require mechanical reperfusion strategies (CABG or PCI)
Currently LMCA obstruction and tripple-vessel disease are contraindications for PCI
Thus, ability to differentiate LMCA obstruction has important management implications (i.e. no Plavix/no cath-lab)
![Page 8: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/8.jpg)
Application 1ACS from left main coronary artery obstruction
Several studies have examined the relationship of ST↑ in aVR with LMCA obstruction:
Author #pts ST↑ (mm) Sens. Spec.
Yamaji/2001 86 0.5 81% 80%
Kosuge/2005 310 0.5 78% 86%
![Page 9: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/9.jpg)
Application 1ACS from left main coronary artery obstruction
Rostoff (2005) found 0.5mm ST↑ twice as likely in pts with LMCA obstruction (69.6% vs. 34.6%)
Kosuge found ST↑ the strongest predictor of LMCA or 3-vessel disease. Also, only ST↑ in aVR (>0.5mm) and ↑TnT were independent predictors of adverse clinical events at 90d (OR 13.8 and 7.9 respectively)
Barrabes (2003) found that in hosp. mortality increased with increasing ST↑ (1.3% if 0mm, 8.6% if 0.5-1mm and 19.4% if >1mm)
![Page 10: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/10.jpg)
Case 2
27M with pleuritic chest painStarted 2 days agoWorse when supine and with UL movementNo tendernessNo associated symptoms
PMHx:Occasional URTI
![Page 11: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/11.jpg)
Case 2
![Page 12: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/12.jpg)
Application 2Acute Pericarditis
ECG changes classically divided into four stages:
1. Diffuse ST↑ (concave up) in almost all leads with reciprocal ST↓ in aVR
2. ST segs return to baseline, flattening of T-waves
3. T-wave inversion
4. Resolution of all previous changes
![Page 13: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/13.jpg)
Application 2Acute Pericarditis
Pts do not necessarily progress through these stages at all, let alone in an orderly fashion
PR segment depression not traditionally included in these stages but found to be of diagnostic significance by Spodick (1973)
Numerous case studies demonstrate a potential role for PR elevation in aVR for diagnosis of acute pericarditis
Only one study (50 pts) has formally examined aVR PR elevation (present in 82%, similar to ST↑)
![Page 14: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/14.jpg)
Case 3
38F found down in apartment by friendLast seen normal 4h prior agoLethargic (GCS 12-13)Anticholinergic toxidrome
PMHx:Depression, several previous suicide
attempts
![Page 15: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/15.jpg)
Case 3
![Page 16: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/16.jpg)
Application 3Tricyclic Antidepressant Ingestion
Often non-specific presentation of altered mental status and an anticholinergic toxidrome
ECG changes typically precede clinically apparent neurological and cardiac toxicity
ECG can demonstrate sinus tach with QRS widening, a deep S-wave in lead I, a rightward axis and a characteristic R-wave in aVR
![Page 17: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/17.jpg)
Application 3Tricyclic Antidepressant Ingestion
Changes specific to aVR:Increased amplitude of the terminal R-
wave (>3mm)
• Only ECG variable to reliably predict seizure or arrhythmia (Liebelt 1995)
Increased R-wave to S-wave ratio (>1.0)
![Page 18: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/18.jpg)
Case 4
17M with syncopal episodeOccurred 1h after basketball practiceHas had “dizziness” several times
before
PMHx: Nil
O/E: HR 270, otherwise normal
![Page 19: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/19.jpg)
Case 4
![Page 20: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/20.jpg)
Case 4
![Page 21: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/21.jpg)
Application 4Pre-excitation syndrome related narrow complex tachycardia
Several case studies have proposed a role for using ST↑ in lead aVR to differentiate AVNRT from AVRT
One study (Ho et al, 2003) examined 338 pts with narrow-complex tachycardiaAVRT was differentiated from AVNRT with
a sens of 71% and a spec of 70%
![Page 22: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/22.jpg)
Take-Home Points
1. ACSST↑ in aVR of > 0.5mm is reasonably sensitive and specific for LM disease
Management implications (surgery)
Prognostic implications
![Page 23: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/23.jpg)
Take-Home Points
2. Acute PericarditisPR elevation in aVR may be a clue to the diagnosis
![Page 24: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/24.jpg)
Take-Home Points
3. TCA toxicityAn R-wave >3mm in aVR is as sensitive as a QRS wider than 100ms for both seizures and arrhythmias
![Page 25: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/25.jpg)
Take-Home Points
4. Preexcitation syndrome related narrow-complex tachycardiaST↑ in aVR provides a clue to differentiate AVNRT from AVRT
![Page 26: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/26.jpg)
ReferencesBarrabes, JA., et al. 2003. Prognostic value of lead aVR in patients with a first non-ST segment elevation acute myocardial
infaction. Circulation. 108:814-9
Gorgels, AP., et al. 2001. Lead aVR, a mostly ignored but very valuable lead in clinical electrocardiography. J Am Coll Cardiol. 38:1355-6.
Ho, YL., et al. 2003. Usefulness of ST-segment elevation in lead aVR during tachycardia for determining the mechanismof narrow QRS complex tachycardia. Am J Cardiol. 92:1424-8.
Kosuge, M., et al. 2005. Predictors of left main or three-vessel disease in patients who have acute coronary syndromes with non-ST segment elevation. Am J Cardiol. 95:1366-9.
Kosuge, M., et al. 2006. Combined prognostic utility of ST segment in lead aVR and troponin T on admission in non-ST-segment elevation acute coronary syndromes. Am J Cardiol. 97:334-9.
Liebelt, EL., et al. 1995. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 26:195-201.
Rostoff, P., et al. 2005. Value of lead aVR in the detection of significant left main coronary artery stenosis in acute coronary syndrome. Kardiol Pol. 62:128-37.
Spodick, DH. 1973. Diagnostic electrocardiographic sequences in acute pericarditis. Significance of PR segment and PR vector changes. Circulation. 48:575-80.
Yamaji, H., et al. 2001. Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVRwith less ST segment elevation in lead V(1). J Am Coll Cardiol. 38:1348-54.
![Page 27: Applications of Lead aVR ECG Rounds February 15, 2007 James Huffman, PGY-1.](https://reader036.fdocuments.in/reader036/viewer/2022062720/56649f155503460f94c2b4f4/html5/thumbnails/27.jpg)
Questions?